drugset / Trial / NCT00940901
Sildenafil for Treatment of Priapism in Men With Sickle Cell Anemia
RandomizedParallel-groupTriple-blindTreatment
Summary
This research is being done to evaluate if the phosphodiesterase type 5 (PDE5) inhibitor sildenafil has an effect on the frequency of recurrent priapism and the quality of life of males with sickle cell disease (SCD).
Timeline
- Start
- 2008-06
- Primary completion
- 2012-11
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | 50 mg | Oral |